Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271180 · ClinicalTrials.gov registry record
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
A clinical trial of Heart Failure and Bradycardia, sponsored by Medtronic.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 20
- Study locations
NCT00271180: Recruiting study of Heart Failure and Bradycardia, sponsored by Medtronic.
NCT00271180 is a study of Heart Failure and Bradycardia that is actively recruiting participants, run by Medtronic. The registered enrollment target is 20,000 participants, above the 1,999-participant average among 397 other Heart Failure trials with a reported enrollment target (901% higher). The trial reports 20 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00271180, a study of Heart Failure and Bradycardia, is actively recruiting participants, sponsored by Medtronic.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Primary Outcome
All follow-up visits will be utilized in the analyses. This is an observational study that does not have a statistically powered primary hypothesis. Therefore, a specific study sample size is not applicable.
Conditions Studied
Interventions
- DEVICE Device
Study Locations (20)
California
- - Bakersfield
- - Chula Vista
- - La Jolla
- - Los Angeles
- - Palm Springs
- - Rancho Mirage
- - Redwood City
- - Salinas
- - San Diego
- - Stanford
- - Torrance
- - Van Nuys
- - Ventura
Arkansas
- - Jonesboro
- - Little Rock
Colorado
- - Aurora
- - Centennial
Alabama
- - Birmingham
Alaska
- - Anchorage
Arizona
- - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 1983-01 |
| Est. Completion | 2040-12 |
What NCT00271180 shows while recruiting
NCT00271180 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,999-participant average among 397 other Heart Failure trials with a reported enrollment target (901% higher).
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Device is the first listed.
NCT00271180 names 20 study sites across 6 states, led by California, Arkansas, Colorado.
Frequently Asked Questions
What is clinical trial NCT00271180 about?
NCT00271180 is a clinical study titled "Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products". The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
What is the current status of trial NCT00271180?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 1983-01. Estimated completion is 2040-12.
What conditions does trial NCT00271180 study?
This clinical trial studies the following conditions: Heart Failure, Bradycardia, Arrhythmia, Sinus Tachycardia.
What interventions are being tested in trial NCT00271180?
The interventions under investigation include: Device (DEVICE).
Who is sponsoring clinical trial NCT00271180?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271180 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00271180's enrollment target sits among peer trials
20,000 9th of 397 higher than 389 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- NCT03115710 · 20,000 participants
The K-Map Study, Global Prevalence of KC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia